Home/Filings/4/0001209191-19-006309
4//SEC Filing

Radford Jason W. 4

Accession 0001209191-19-006309

CIK 0001131324other

Filed

Jan 30, 7:00 PM ET

Accepted

Jan 31, 8:22 PM ET

Size

7.3 KB

Accession

0001209191-19-006309

Insider Transaction Report

Form 4
Period: 2019-01-29
Radford Jason W.
Chief Legal Officer
Transactions
  • Award

    Employee Stock Option (right to buy) Holding

    2019-01-29+16,27016,270 total
    Exercise: $72.52Exp: 2029-01-29Common Stock (0 underlying)
  • Award

    Common Stock

    2019-01-29+7,07038,396 total
Footnotes (3)
  • [F1]Restricted stock units awarded on January 29, 2019 which vest as to 1/3 of the shares on each of February 15, 2020, 2021 and 2022.
  • [F2]Includes an aggregate of 24,447 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
  • [F3]The option becomes exercisable as to 25% of the shares on January 29, 2020, and becomes exercisable as to 1/48th of the shares each full month thereafter.

Issuer

GENOMIC HEALTH INC

CIK 0001131324

Entity typeother

Related Parties

1
  • filerCIK 0001649199

Filing Metadata

Form type
4
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 8:22 PM ET
Size
7.3 KB